BIOMARIN PHARMACEUTICAL INC Insider Trading for June 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for June 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 82.77 | 550 | 45,524 | 13,860 | 14.4 K to 13.9 K (-3.82 %) |
Jun 20 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.54 | 41,666 | 730,822 | 208,334 | |
Jun 20 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.55 | 41,666 | 3,356,196 | 378,584 | 420.3 K to 378.6 K (-9.91 %) |
Jun 20 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.54 | 41,666 | 730,822 | 420,250 | 378.6 K to 420.3 K (+11.01 %) |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 89.14 | 1,649 | 146,992 | 46,944 | 48.6 K to 46.9 K (-3.39 %) |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | Slamon Dennis | Director | Option Exercise | A | 89.52 | 4,440 | 397,469 | 4,440 | |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | Slamon Dennis | Director | Grant | A | 0.00 | 1,510 | 0 | 7,835 | 6.3 K to 7.8 K (+23.87 %) |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Option Exercise | A | 89.52 | 2,220 | 198,734 | 2,220 | |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 760 | 0 | 2,860 | 2.1 K to 2.9 K (+36.19 %) |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Option Exercise | A | 89.52 | 4,440 | 397,469 | 4,440 | |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Grant | A | 0.00 | 1,510 | 0 | 26,760 | 25.3 K to 26.8 K (+5.98 %) |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 89.52 | 4,440 | 397,469 | 4,400 | |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Grant | A | 0.00 | 1,510 | 0 | 24,010 | 22.5 K to 24 K (+6.71 %) |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | A | 89.52 | 4,440 | 397,469 | 4,440 | |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Grant | A | 0.00 | 1,510 | 0 | 14,410 | 12.9 K to 14.4 K (+11.71 %) |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Option Exercise | A | 89.52 | 4,440 | 397,469 | 0 | |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Grant | A | 0.00 | 1,510 | 0 | 37,135 | 35.6 K to 37.1 K (+4.24 %) |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | A | 89.52 | 4,440 | 397,469 | 4,440 | |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Grant | A | 0.00 | 1,510 | 0 | 27,760 | 26.3 K to 27.8 K (+5.75 %) |
Jun 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Payment of Exercise | F | 90.00 | 1,644 | 147,960 | 128,742 | 130.4 K to 128.7 K (-1.26 %) |
Jun 07 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 90.00 | 1,488 | 133,920 | 59,809 | 61.3 K to 59.8 K (-2.43 %) |
Jun 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 90.00 | 6,640 | 597,600 | 378,584 | 385.2 K to 378.6 K (-1.72 %) |
Jun 07 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 90.00 | 2,036 | 183,240 | 113,878 | 115.9 K to 113.9 K (-1.76 %) |
Jun 07 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Payment of Exercise | F | 90.00 | 1,488 | 133,920 | 72,956 | 74.4 K to 73 K (-2.00 %) |
Jun 07 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Payment of Exercise | F | 90.00 | 1,801 | 162,090 | 48,593 | 50.4 K to 48.6 K (-3.57 %) |
Jun 07 2016 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 90.00 | 376 | 33,840 | 14,547 | 14.9 K to 14.5 K (-2.52 %) |
Jun 02 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Option Exercise | M | 39.06 | 16,896 | 659,958 | 2,604 | |
Jun 02 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 89.35 | 3,945 | 352,486 | 50,394 | 54.3 K to 50.4 K (-7.26 %) |
Jun 02 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 90.00 | 16,896 | 1,520,640 | 54,339 | 71.2 K to 54.3 K (-23.72 %) |
Jun 02 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Buy | M | 39.06 | 16,896 | 659,958 | 71,235 | 54.3 K to 71.2 K (+31.09 %) |